Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | NSD2 | O96028 | 2/20 | 0.57 |
| ▸ | MMP14 | P50281 | 2/20 | 0.57 |
| ▸ | CASP6 | P55212 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | ATIC | P31939 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112102 | 1.00 | EGFR (0.69) | EGFRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL29378452 | 1.00 | EGFR (0.69) | EGFRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL144370 | 0.98 | EGFR (0.67) | EGFRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL144372 | 0.98 | EGFR (0.67) | EGFRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL29555012 | 0.86 | EGFR (0.67) | EGFRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL94484 | 0.86 | EGFR (0.67) | EGFRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL144371 | 0.86 | EGFR (0.67) | EGFRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL5364165 | 0.85 | RPS6KA3 (0.62) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL9099069 | 0.84 | RPS6KA3 (0.55) | EGFRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL4842755 | 0.84 | RPS6KA3 (0.55) | EGFRMAPTMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11940387-B2 | Portable liquid analyzer | VERITEQUE USA, INC. (US) | 2024-03-26 | — | — | US | claimed |
| US-20200371038-A1 | PORTABLE LIQUID ANALYZER | S2 DETECTION (NEVADA) INC. | 2020-11-26 | — | — | US | claimed |
| EP-2368558-A1 | Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates | Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch (DE) | 2011-09-28 | — | — | EP | claimed |
| EP-0696269-B1 | PROCESS FOR PREPARING SUBSTITUTED AROMATIC AMINES | MONSANTO CO (US) | 1999-06-30 | — | — | EP | claimed |
| EP-0641313-B1 | PROCESS FOR PREPARING SUBSTITUTED AROMATIC AMINES | MONSANTO CO (US) | 1997-01-22 | — | — | EP | claimed |
| US-20230131243-A1 | METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1 | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2023-04-27 | — | — | US | disclosed |
| US-20230131243-A1 | METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1 | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2023-04-27 | — | — | US | disclosed |
| US-11541073-B2 | Methods of attenuating an immune response by inhibition of BFL1 | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2023-01-03 | — | — | US | disclosed |
| US-11110121-B2 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances | CLARIANT INTERNATIONAL LTD. (CH) | 2021-09-07 | — | — | US | disclosed |
| US-20210171883-A1 | ANTIVIRAL WIPER | FUJIFILM CORPORATION (JP) | 2021-06-10 | — | — | US | disclosed |
| US-20210113604-A1 | METHODS OF TREATMENT BY INHIBITION OF BFL1 | CHILDREN'S HOSPITAL MEDICAL CENTER | 2021-04-22 | — | — | US | disclosed |
| US-10406135-B2 | Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group | CLARIANT INTERNATIONAL LTD. (CH) | 2019-09-10 | — | — | US | disclosed |
| EP-1400574-A1 | Colour changing paint | Akzo Nobel Decorative Coatings Ltd. (GB) | 2004-03-24 | — | — | EP | disclosed |
| EP-1374837-A1 | Aerosol foam for treating the hair | Wella Aktiengesellschaft (DE) | 2004-01-02 | — | — | EP | disclosed |
| EP-1362576-A2 | Non aerosol and aerosol hair mousse | Wella Aktiengesellschaft (DE) | 2003-11-19 | — | — | EP | disclosed |
| EP-1358929-A2 | Method for the production of hair or skin cosmetic products using apparatus with microstructures | Wella Aktiengesellschaft (DE) | 2003-11-05 | — | — | EP | disclosed |
| US-6620420-B2 | Cosmetic or dermatological application | BEIERSDORF AG (DE) | 2003-09-16 | — | — | US | disclosed |
| CN-1406577-A | Cosmetic W/O emulsion and agents for skin containing amino substituted hydroxy diphenyl ketone | BASF AG (DE) | 2003-04-02 | — | — | CN | disclosed |
| CN-1406576-A | Oil in water low emulsifier or non-emulsifier system containing stabilizer and amiho substituted hydroxy diphenyl ketone | BASF AG (DE) | 2003-04-02 | — | — | CN | disclosed |
| US-4084983-A | ALUMINUM FLAKES ON A COATING OF ALUMINUM HYDROXIDE | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11110121-B2 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances | GPX4, LPO, CAT | EGFR 3601/4885MAPT 1729/4885MEN1 3224/4885 |
| US-20230131243-A1 | METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1 | CD74, IRF3, IRF2BP2 | EGFR 3604/4885MAPT 4608/4885MEN1 4808/4885 |
| US-20210171883-A1 | ANTIVIRAL WIPER | CGAS, PRKX, PDE4C | EGFR 4834/4885MAPT 4519/4885MEN1 3305/4885 |
| US-20210113604-A1 | METHODS OF TREATMENT BY INHIBITION OF BFL1 | DNASE1L3, ILF2, NCF1 | EGFR 3315/4885MAPT 4347/4885MEN1 4786/4885 |
| US-10406135-B2 | Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group | ADH5, ADH1A, ADH1C | EGFR 1504/4885MAPT 1822/4885MEN1 3537/4885 |
| US-11541073-B2 | Methods of attenuating an immune response by inhibition of BFL1 | CD74, IRF3, IRF2BP2 | EGFR 3604/4885MAPT 4608/4885MEN1 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.